Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Regulatory
Judge allows states to resurrect battle over mifepristone access
Idaho, Kansas and Missouri may move forward on a challenge to the regulatory clearance of mifepristone, a judge ruled Thursday.
Dave Muoio
Jan 20, 2025 10:00am
In waning days, Biden withdraws another contraception rule
Jan 14, 2025 5:00pm
Big Health receives FDA clearance for DTx for insomnia
Aug 8, 2024 11:00am
FDA releases roster of digital health advisory committee
Aug 6, 2024 3:15pm
SCOTUS sides 9-0 with FDA, rejects mifepristone challenge
Jun 13, 2024 10:51am
Why the road to psychedelic coverage runs through employers
May 22, 2024 4:30pm
